Alicia Arenas

Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm

I. Rapado, J. Martínez-López, F. Gilsanz, 2013, British journal of haematology.

Donor Chimerism, Kir Ligand Mismatch and Cytokine Levels (Tnfñ, Il17, Gmcsf, l1ò) and their Association with Graft Rejection in Liver Transplant Recipients

M. Serrano, J. Vicario, I. Rapado, 2016 .

Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera

J. Albar, J. Martínez-López, A. Paradela, 2013, Molecular Cancer.

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia

G. Gómez-López, I. Rapado, J. Martínez-López, 2019, Scientific Reports.

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

I. Buño, I. Mahíllo-Fernández, P. Llamas, 2017, PloS one.

Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy

J. Martínez-López, J. Bautista, Alicia Arenas, 2019, Antioxidants.

Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.

E. Cabiscol, J. Tamarit, J. Ros, 2011, Archives of biochemistry and biophysics.